Short interest in CRISPR Therapeutics AG (NASDAQ:CRSP) increased during the last reporting period, rising from 21.69M to 22.62M. This put 26.43% of the company's publicly available shares short.

Based on the recent average volume of 1.71M shares traded per day, it would take 13.23 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.